Jan 21, 2021 7:00am EST Sutro Biopharma Announces First Patient Dosed in the Dose-Expansion Study of STRO-002 in Patients with Ovarian Cancer
Jan 5, 2021 7:00am EST Sutro Biopharma to Present at the 39th Annual J.P. Morgan Virtual Healthcare Conference